Clinical Trials
5 trialsNCT04601584 2024-03-06
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
AO GENERIUM
Phase 1/2 Unknown
NCT06075212 2023-10-10
Immune Reconstitution After Allo-HSCT and Blinatumomab
Sichuan University
Unknown
NCT02670564 2019-04-16
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Swiss Pediatric Oncology Group
Phase 4 Unknown
NCT00315419 2010-04-21
Identifying Characteristics of Bone Marrow Failure Syndromes
Office of Rare Diseases (ORD)
Unknown
NCT00801580 2009-09-15
My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia
University of Bologna
Phase 2 Unknown